This application relates to the field of medical devices, and in particular to a closed-loop control system for pulse ablation, which is used for treating arrhythmia and atrial fibrillation.
The ablation treatment of rapid arrhythmia is achieved through minimally invasive ablation, which damages the myocardial tissues that cause the occurrence of arrhythmia. Minimally invasive ablation is used for treating atrioventricular (nodal) reentrant tachycardia, atrial flutter, atrial fibrillation, tachyarrhythmia, atrial premature beats, and atrial and ventricular premature beats.
Radio-frequency current energy is currently the most commonly used energy source. The electrode at the head of the ablation catheter releases low voltage and high frequency (30 kHz-1.5 MHz) radio-frequency electric energy, which is converted into thermal energy between the head of the ablation catheter and the local myocardial intima to heat the head of the ablation catheter to 42° C.-50° C., thus causing dehydration, degeneration and necrosis of specific local myocardial cells, and change in autonomy and conductivity to cure arrhythmia. Due to thermal conductivity characteristics, it is easy to have adverse effects on the targeted myocardial tissues and other surrounding tissue structures, resulting in esophageal damage including esophageal fistula formation, septal nerve injury, pulmonary vein stenosis, coagulation/thrombus formation, and subsequent thromboembolism causing the risk of cerebral embolism.
Pulse electric field ablation releases a biphasic pulse electric field with high electric field intensity through a direct-current pulse generator, forming a local high voltage difference and releasing non-thermal energy of the high electric field to selectively act on the myocardial area to achieve irreversible electroporation (IRE) of the myocardial cytoplasmic membrane, which causes transmural damage, leakage of cell contents, and death of myocardial cells. The long-term formation of fibrous scars is the same as that of radio-frequency ablation. The myocardial tissues within the strong electric field area are an effective ablation site during pulsed electric field ablation, which can be precisely controlled to reduce the requirement for electrode attachment pressure. It is non-thermal tissue ablation, during which it will not damage the tissue scaffold structure, is not affected by the blood flow “heat sink effect”, and will not produce local thrombus ablation. It has a relatively wide therapeutic energy window and tissue resistance specificity. The ablation voltage prioritizes myocardial damage, with minimal and no damage to adjacent tissues such as blood vessels, nerves, and esophagus.
At present, most electric pulse generators work in an open-loop state, can only implement real-time transmission of electric pulses, cannot dynamically optimize and adjust the parameters of electric pulses and electrode discharge according to the ablation effect, thus increasing the risk in treatment.
The purpose of this application is to provide a closed-loop control system for pulse ablation, which samples a change amplitude of a potential amplitude signal at an ablation site, adjusts waveform parameters of a pulse signal output by a pulse transmission module according to the corresponding change amplitude to form a control loop, and dynamically optimizes and adjusts the electric pulse parameter and electrode discharge in real time according to the ablation effect.
This application discloses a closed-loop control system for pulse ablation, including an electric pulse host and an electrode group including a plurality of electrodes; the electric pulse host including a main control module, a pulse transmission module, an electrophysiological signal sampling module, a first electrode control unit and a second electrode control unit; the main control module being sequentially connected with the pulse transmission module, the first electrode control unit and the electrode group, the main control module controlling the pulse transmission module to output a pulse signal and selecting a specific electrode through the first electrode control unit to release the pulse signal; the main control module being sequentially connected with the electrophysiological signal sampling module, the second electrode control unit and the electrode group, the main control module selecting an electrode through the second electrode control unit and sampling an electrocardiogram signal through the electrophysiological signal sampling module, the electrocardiogram signal referring to a potential amplitude signal between the selected electrodes; the main control module determining a treatment progress according to the sampled electrocardiogram signal and adjusting the pulse signal output by the pulse transmission module in real time according to the treatment progress.
Further, the pulse transmission module and the electrophysiological signal sampling module work alternately and switch once every heartbeat cycle.
Further, the main control module determining a treatment progress according to the sampled electrocardiogram signal and adjusting the pulse signal output by the pulse transmission module in real time according to the treatment progress refers to:
Further, the closed-loop control system for pulse ablation further includes a voltage and current sensor configured to monitor arc discharge caused by a position change between the electrodes; after the pulse signal is triggered, perform voltage and current sampling after a delay of certain time; perform voltage and current sampling in time smaller than the pulse width, transmit a sampling signal in real time to the main control module for analysis after analog-to-digital conversion, and perform arc determination by determining change characteristics of voltage and current.
Further, the main control module controls the pulse transmission module to release the pulse signal in an electrocardiogram refractory period according to the electrocardiogram signal.
Further, the closed-loop control system for pulse ablation further includes a man-machine interaction module, the man-machine interaction module is connected with the main control module and configured to set parameters, and the parameters include the voltage amplitude and pulse width of the pulse signal.
Further, the pulse transmission module includes a high-voltage power supply and a pulse generation circuit, and the pulse generation circuit achieves a bidirectional pulse by adopting a four-way switch module.
Further, the main control module achieves single-electrode pulse transmission control and single-electrode electrocardiograph signal sampling through the first electrode control unit and the second electrode control unit.
Beneficial effects: (1) according to the data feedback from the electrophysiological signal sampling module, this application determines the treatment progress in the treatment process, thus helping to prevent excessive pulse transmission and incomplete treatment; (2) the cardiac electrophysiological signals can be detected and fed back while performing high-voltage pulse ablation of myocardial cells, the acting pulse waveform parameters including voltage amplitude, pulse width, pulse phase, and the pulse cycle can be adjusted in real time; (3) the arc discharge caused by the position change between the electrodes can be monitored, thus preventing the occurrence of abnormal arcs and making equipment treatment safety higher.
The various technical features disclosed in the summary, the various technical features disclosed in the following embodiments and examples, and the various technical features disclosed in the drawings can be freely combined with each other to form various new technical solutions (these technical solutions should be considered as already recorded in the description), unless the combination of such technical features is technically infeasible.
In the following description, many technical details are provided to help readers better understand this application. However, those skilled in the art can understand that even without these technical details and various changes and modifications based on the following embodiments, the technical solution set forth by this application can still be achieved.
In order to make the purpose, technical solution, and advantages of this application clearer, the embodiments of this application will be further described below in detail with reference to the drawings.
Disclosed is a closed-loop control system for pulse ablation, which includes an electric pulse host 100 and an electrode group including a plurality of electrodes 200. One ends of the plurality of electrodes 200 pass through an ablation mapping catheter 300 to reach myocardial tissues (ablation site), while the other ends receive an electric pulse signal and conduct the electric pulse signal to the ablation site.
Referring to
The pulse transmission module includes a high-voltage power supply and a pulse generation circuit. The pulse generation circuit achieves a bidirectional pulse by adopting a four-way switch module. Referring to
The pulse transmission module 120 and the electrophysiological signal sampling module 130 work alternately and switch once every heartbeat cycle. By switching the relay corresponding to the electrode, single-electrode pulse transmission control and single-electrode signal sampling can be achieved. The main control module 110 controls the pulse transmission module 120 to release a pulse signal in an electrocardiogram refractory period according to the electrocardiogram signal. Referring to
The main control module 110 determines a treatment progress according to the sampled electrocardiogram signal and adjusts the pulse signal output by the pulse transmission module 120 in real time according to the treatment progress. The electrocardiogram signal refers to a potential amplitude signal between the selected electrodes, detected from two adjacent signals, such as electrode 1 and electrode 2, electrode 2 and electrode 3, electrode 3 and electrode 4, till electrode n−1 to electrode n. Specifically, it includes the follows:
Clinical data show that as the ablation process progresses, the electrocardiogram signal will continue to decrease, that is, the potential amplitude signal measured by the electrodes will gradually decrease. If the newly sampled electrocardiogram signal presents no change, it indicates that the current electrode position may not be the optimal position and needs to be adjusted. When the electrocardiogram signal decreases, it is necessary to compare the decrease amount and decrease amplitude to calculate the percentage of the change amplitude, and the voltage amplitude of the pulse signal or the number of pulses is adjusted according to the change amplitude percentage. When the newly sampled electrocardiogram signal reaches the set second threshold (usually 0.5 mV) or less, it indicates that the ablation process is ended.
In addition, the control system in this embodiment further includes a voltage and current sensor 160 configured to monitor arc discharge caused by a position change between the electrodes. Arc discharge will cause high ionization pressure and the generation of bubbles, which follow blood flow to the lungs and are very dangerous. Referring to
The arc of the electrode is detected by adopting the following method: after the pulse signal is triggered, voltage and current sampling is performed after a delay of certain time; voltage and current sampling is performed in time smaller than the pulse width, and a sampling signal is transmitted in real time to the main control module 110 for analysis after analog-to-digital conversion. Specifically, when an arc occurs, the voltage decreases, the current will increase, arc determination can be performed by determining change characteristics of the voltage and the current.
In addition, the control system in this embodiment further includes a man-machine interaction module 170 connected with the main control module 110 and configured to set parameters. The parameters include the voltage amplitude and pulse width of the pulse signal.
What are described above are just exemplary embodiment of this application and are not intended to limit the scope of protection of this application. Any modifications, equivalent replacements, improvements and the like made within the spirit and principle of this application shall be included in the scope of protection of this application.
Number | Date | Country | Kind |
---|---|---|---|
202111466101.4 | Dec 2021 | CN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CN2022/136315 | 12/2/2022 | WO |